Companies / BOC Sciences / Bevacizumab
BOC Sciences

Bevacizumab | BOC Sciences

Bevacizumab is an angiogenesis inhibiting monoclonal antibody which is commonly used to treat certain metastatic cancers. It acts via inhibiting vascular endothelial growth factor A (VEGF-A).

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
  • See More